Trifarotene is a selective retinoic acid receptor gamma (RAR-γ) agonist. By binding specifically to RAR-γ, the predominant retinoic acid receptor in the epidermis, it modulates gene expression that regulates keratinocyte differentiation and proliferation. This action normalizes the process of skin cell turnover, reducing follicular hyperkeratinization and preventing the formation of new comedones. Additionally, trifarotene exhibits anti-inflammatory effects, which help decrease acne lesion formation and promote skin healing.